API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride

China API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride, Find details about China Levofloxacin Hydrochloride, Levofloxacin from API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride

Model NO.
Dsung-Levofloxacin Hydrochloride
Product Name
Levofloxacin Hydrochloride
Name
Levofloxacin Hydrochloride Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Anti-Infective
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
177325-13-2
Molecular Formua
C18h21clfn3o4
Einecs No.
605-797-4
Boiling Point
571.5 C at 760 Mmhg
Storage Temperature
Room Temperature
Trademark
D-Sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi
Model NO.
Dsung-Levofloxacin Hydrochloride
Product Name
Levofloxacin Hydrochloride
Name
Levofloxacin Hydrochloride Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Anti-Infective
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
177325-13-2
Molecular Formua
C18h21clfn3o4
Einecs No.
605-797-4
Boiling Point
571.5 C at 760 Mmhg
Storage Temperature
Room Temperature
Trademark
D-Sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi
API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride
 API Antibiotics Levofloxacin Pharmaceutical Levofloxacin Hcl Powder Levofloxacin Hydrochloride
 
Product Description
 

API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride

 

API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride

 

Product Details
 

API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride

 

Product NameLevofloxacin Hydrochloride
CAS NO.177325-13-2
Purity99%
Boiling Point571.5 C at 760 mmHg
Appearance and shapeWhite crystal powder
Levofloxacin hydrochloride, the molecular formula is C18H21ClFN3O4, is the hydrochloride of levofloxacin. It is suitable for genitourinary system infections caused by sensitive bacteria. It can also treat typhoid fever, bone and joint infections, skin and soft tissue infections and sepsis and other systemic infections. Levofloxacin hydrochloride is the L-body of ofloxacin, and its antibacterial activity is about twice that of ofloxacin. Its main mechanism of action is to inhibit the activity of bacterial DNA gyrase (bacterial topoisomerase II) and hinder bacterial DNA replication . Features of broad antibacterial spectrum and strong antibacterial effect. For most Enterobacteriaceae bacteria, such as Escherichia coli, Klebsiella, Serratia, Proteus, Shigella, Salmonella, Citrobacter, Acinetobacter and Pseudomonas aeruginosa Gram-negative bacteria such as Monascus, Haemophilus influenzae and Neisseria gonorrhoeae have strong antibacterial activity. It also has a good antibacterial effect on some methicillin-sensitive Staphylococcus, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus hemolyticus and other gram-positive bacteria and Legionella, Mycoplasma, Chlamydia, but has an effect on anaerobic bacteria and enterococci. Poor.
Application & Function
 

API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride

This product is suitable for the following mild and moderate infections caused by sensitive bacteria;
1. Respiratory system infection: acute bronchitis, acute exacerbation of chronic bronchitis, diffuse bronchiolitis, bronchiectasis complicated infection, pneumonia, tonsillitis (peritonsillar abscess);
2. Urinary system infection: pyelonephritis, complicated urinary tract infection, etc.;
Reproductive system infections: acute prostatitis, acute epididymitis, uterine cavity infection, uterine adnexitis, pelvic inflammatory disease (metronidazole can be used in combination when anaerobic infection is suspected);
3. Skin and soft tissue infections: infectious impetigo, cellulitis, lymphatic (nodular) inflammation, subcutaneous abscess, perianal abscess, etc.;
Intestinal infections: bacillary dysentery, infectious enteritis, Salmonella enteritis, typhoid fever and paratyphoid fever;
4. Various infections in patients with sepsis, neutropenia and immunocompromised;
5. Other infections: mastitis, trauma, burns and postoperative wound infections, abdominal cavity infections (with metronidazole if necessary), cholecystitis, cholangitis, bone and joint infections, and ENT infections, etc.

Specification
 

API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride

API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride

 

API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride

 

 

API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride

 

API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride

 

API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride

 

API Antibiotics Levofloxacin Pharmaceutical Levofloxacin HCl Powder Levofloxacin Hydrochloride